脑炎疫苗诱导的针对新冠病毒的交叉保护可能是一些国家死亡率相对较低的原因。
Cross-Protection Induced by Encephalitis Vaccines against COVID-19 Might be a Reason for Relatively Lower Mortality Rate in Some Countries.
作者信息
Katoh Shojiro, Obayashi Toshihiko, Ganesh Jegatheesan Saravana, Iwasaki Masaru, Preethy Senthilkumar, Abraham Samuel Jk
机构信息
Edogawa Evolutionary Lab of Science, Edogawa Hospital Campus, 2-24-18, Higashi-Koiwa, Edogawa, Tokyo 133-0052, Japan.
Edogawa Hospital, 2-24-18, Higashi-Koiwa, Edogawa, Tokyo 133-0052, Japan.
出版信息
Arch Acad Emerg Med. 2020 Apr 21;8(1):e54. eCollection 2020.
Abstract
COronaVIrus Disease 2019 (COVID-19) is an on-going pandemic attributed to a novel virus named SARS-CoV-2. Comparing the statistics of incidence and death rates between nations reveals that there is discrepancy amongst countries in these regards, even between countries that share borders. We herein present information from the literature indicating how cross-protection against COVID-19 conferred by the encephalitis vaccine could be the reason for lower fatality rate in the countries where immunization against encephalitis is widespread or included in national programs. This may pave the way for arriving at efficient prevention strategies as well as vaccine development.
摘要
2019冠状病毒病（COVID-19）是由一种名为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的新型病毒引起的正在流行的疾病。比较各国的发病率和死亡率统计数据发现，在这些方面各国之间存在差异，即使是接壤国家之间也是如此。我们在此提供文献中的信息，表明流行性乙型脑炎疫苗对COVID-19的交叉保护作用可能是流行性乙型脑炎免疫接种普遍或纳入国家计划的国家死亡率较低的原因。这可能为制定有效的预防策略以及疫苗研发铺平道路。
相似文献
1
Cross-Protection Induced by Encephalitis Vaccines against COVID-19 Might be a Reason for Relatively Lower Mortality Rate in Some Countries.脑炎疫苗诱导的针对新冠病毒的交叉保护可能是一些国家死亡率相对较低的原因。
Arch Acad Emerg Med. 2020 Apr 21;8(1):e54. eCollection 2020.
2
Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.日本脑炎病毒 I 型和 III 型在小鼠之间的部分交叉保护作用。
PLoS Negl Trop Dis. 2019 Aug 2;13(8):e0007601. doi: 10.1371/journal.pntd.0007601. eCollection 2019 Aug.
3
Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.使用北京-1株DNA疫苗诱导对两株台湾野生型日本脑炎病毒的交叉保护。
Vaccine. 2003 Sep 8;21(25-26):3938-45. doi: 10.1016/s0264-410x(03)00277-9.
4
Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.日本脑炎病毒 prM-E 抗原免疫可预防小鼠感染四种不同血清型登革热病毒。
Appl Microbiol Biotechnol. 2019 Jun;103(12):4977-4986. doi: 10.1007/s00253-019-09798-9. Epub 2019 Apr 29.
5
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?卡介苗对抗新型冠状病毒肺炎：一种古老疫苗的新使命？
Front Pharmacol. 2020 Jul 9;11:1050. doi: 10.3389/fphar.2020.01050. eCollection 2020.
6
Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.初免和加强免疫接种乙型脑炎疫苗的交叉保护作用：一项为期两年的随访研究。
Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.
7
Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.基于欧洲型的现有疫苗对远东和西伯利亚型蜱传脑炎（TBE）病毒的免疫原性：系统评价和荟萃分析。
Hum Vaccin Immunother. 2014;10(10):2819-33. doi: 10.4161/hv.29984.
8
Importance of early precautionary actions in avoiding the spread of COVID-19: Saudi Arabia as an Example.早期预防措施在避免新冠病毒传播中的重要性：以沙特阿拉伯为例。
Saudi Pharm J. 2020 Jul;28(7):898-902. doi: 10.1016/j.jsps.2020.05.005. Epub 2020 May 22.
9
Japanese encephalitis vaccines--needs, flaws and achievements.日本脑炎疫苗——需求、缺陷与成就
Biol Chem. 2008 May;389(5):547-50. doi: 10.1515/bc.2008.062.
10
Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China.中国东部省份浙江的乙型脑炎血清分子流行病学
PLoS Negl Trop Dis. 2016 Aug 25;10(8):e0004936. doi: 10.1371/journal.pntd.0004936. eCollection 2016 Aug.
引用本文的文献
1
Vector-borne diseases and their role in COVID-19 dynamics and death rates: focus on India.媒介传播疾病及其在新冠疫情动态和死亡率中的作用：以印度为重点。
Folia Microbiol (Praha). 2025 Aug 9. doi: 10.1007/s12223-025-01313-0.
2
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.先前存在的蜱传脑炎病毒抗体对严重急性呼吸综合征冠状病毒 2 没有中和作用：一项前瞻性医护人员研究。
Sci Rep. 2021 Dec 17;11(1):24198. doi: 10.1038/s41598-021-03685-y.
3
What could explain the late emergence of COVID-19 in Africa?如何解释新冠病毒病在非洲出现较晚的情况？
New Microbes New Infect. 2020 Nov;38:100760. doi: 10.1016/j.nmni.2020.100760. Epub 2020 Sep 22.
4
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate.抗疟青蒿素复方疗法（ACT）与非洲的 COVID-19：甲氟喹-青蒿琥酯体外抑制 SARS-CoV-2 复制。
Int J Infect Dis. 2020 Oct;99:437-440. doi: 10.1016/j.ijid.2020.08.032. Epub 2020 Aug 14.
5
Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation.由于 SARS-CoV-2 和 COVID-19，中欧和东亚的死亡率存在明显差异：可能解释的四个假设。
Med Hypotheses. 2020 Nov;144:110160. doi: 10.1016/j.mehy.2020.110160. Epub 2020 Aug 5.
6
Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.免疫失调在特定 COVID-19 患者群体死亡率升高中的作用，以及通过营养补充剂增强免疫力的策略。
Front Immunol. 2020 Jul 9;11:1548. doi: 10.3389/fimmu.2020.01548. eCollection 2020.
本文引用的文献
1
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2.首例与 SARS-CoV-2 相关的脑膜炎/脑炎。
Int J Infect Dis. 2020 May;94:55-58. doi: 10.1016/j.ijid.2020.03.062. Epub 2020 Apr 3.
2
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
3
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.SARS-CoV2 的神经侵袭性可能在 COVID-19 患者的呼吸衰竭中起作用。
J Med Virol. 2020 Jun;92(6):552-555. doi: 10.1002/jmv.25728. Epub 2020 Mar 11.
4
The COVID-19 epidemic.新冠疫情。
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.
5
Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice.日本脑炎疫苗在小鼠中诱导产生的针对不同基因型登革病毒的交叉保护作用。
Sci Rep. 2016 Jan 28;6:19953. doi: 10.1038/srep19953.
6
Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.决定TRIM56对黄病毒和冠状病毒抗病毒活性的重叠且独特的分子决定因素。
J Virol. 2014 Dec;88(23):13821-35. doi: 10.1128/JVI.02505-14. Epub 2014 Sep 24.
7
Sense of life worth living (ikigai) and mortality in Japan: Ohsaki Study.日本的生活价值感（生き甲斐）与死亡率：大崎研究
Psychosom Med. 2008 Jul;70(6):709-15. doi: 10.1097/PSY.0b013e31817e7e64. Epub 2008 Jul 2.
8
Japanese encephalitis.日本脑炎
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):405-15. doi: 10.1136/jnnp.68.4.405.
Zotero 插件